Instead of waiting for further degeneration, we act early to protect your spine, extend your healthspan, and preserve the life you love
doi: 10.1016/j.biomaterials.2014.05.053 75 ChenZShiTZhangLZhuPDengMHuangCet al
385 A phase II single-arm clinical trial was conducted to evaluate whether low doses of cyclophosphamide could increase the immunogenicity of p53-SLP in patients with recurrent ovarian cancer
GHK-Cu has significant anti-aging effects as well as antioxidant and anti-inflammatory properties
Front Drug Deliv 5:1644633
Our Academy of Anti-Aging & Regenerative Medicine curriculum includes bioidentical hormone replacement therapy (BHRT), peptide therapy protocols, IV nutrition and hydration therapy, GLP-1 weight management programs, and precision nutrition testing all delivered through live patient training with expert faculty